LENZ Total Assets from 2010 to 2026
| LENZ Stock | 12.74 0.30 2.30% |
Total Assets | First Reported 2020-12-31 | Previous Quarter 217.3 M | Current Value 210.7 M | Quarterly Volatility 119.5 M |
Check LENZ Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LENZ Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 49.6 K, Interest Expense of 48 K or Other Operating Expenses of 42.3 M, as well as many indicators such as Price To Sales Ratio of 6.57, Dividend Yield of 0.4 or PTB Ratio of 2.84. LENZ financial statements analysis is a perfect complement when working with LENZ Therapeutics Valuation or Volatility modules.
LENZ | Total Assets | Build AI portfolio with LENZ Stock |
The evolution of Total Assets for LENZ Therapeutics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how LENZ Therapeutics compares to historical norms and industry peers.
Latest LENZ Therapeutics' Total Assets Growth Pattern
Below is the plot of the Total Assets of LENZ Therapeutics over the last few years. Total assets refers to the total amount of LENZ Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in LENZ Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. LENZ Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LENZ Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 215.3 M | 10 Years Trend |
|
Total Assets |
| Timeline |
LENZ Total Assets Regression Statistics
| Arithmetic Mean | 51,833,481 | |
| Geometric Mean | 297,893 | |
| Coefficient Of Variation | 178.90 | |
| Mean Deviation | 68,932,383 | |
| Median | 6,000 | |
| Standard Deviation | 92,729,167 | |
| Sample Variance | 8598.7T | |
| Range | 260M | |
| R-Value | 0.77 | |
| Mean Square Error | 3780T | |
| R-Squared | 0.59 | |
| Significance | 0.0003 | |
| Slope | 14,079,571 | |
| Total Sum of Squares | 137579.2T |
LENZ Total Assets History
Other Fundumenentals of LENZ Therapeutics
LENZ Therapeutics Total Assets component correlations
Click cells to compare fundamentals
About LENZ Therapeutics Financial Statements
LENZ Therapeutics investors use historical fundamental indicators, such as LENZ Therapeutics' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LENZ Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Assets | 247.6 M | 260 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LENZ Stock Analysis
When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.